Filing Details

Accession Number:
0001140361-11-022928
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-04-22 14:13:24
Reporting Period:
2011-03-09
Filing Date:
2011-04-22
Accepted Time:
2011-04-22 14:13:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Holdings Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
70858 Bank Of America Corp /De/ Bank Of America Corporate Center
100 N Tryon St
Charlotte NC 28255
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-09 100 $30.00 105,296,865 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-03-18 100 $32.16 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-03-23 100 $32.48 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-03-23 100 $32.49 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-03-23 100 $31.59 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-03-23 100 $32.04 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-03-29 200 $33.98 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-03-30 200 $33.99 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-03-30 500 $33.99 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-04-01 220 $33.76 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-04 500 $33.42 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-04-05 220 $33.42 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-04-07 150 $33.20 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-04-08 150 $33.20 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-04-11 1,300 $32.10 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-04-11 5,000 $32.16 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-04-11 3,100 $32.10 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-04-11 600 $32.10 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Acquisiton 2011-04-11 300 $32.15 84,307,409 No 4 P Indirect By Subsidiary
Common Stock Disposition 2011-04-13 100 $32.29 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-13 200 $32.29 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-13 9,100 $31.91 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-13 300 $31.90 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-13 600 $31.92 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Disposition 2011-04-14 46 $32.20 84,307,409 No 4 S Indirect By Subsidiary
Common Stock Acquisiton 2011-04-15 46 $32.09 84,307,409 No 4 P Indirect By Subsidiary
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 P Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 S Indirect By Subsidiary
No 4 P Indirect By Subsidiary
Footnotes
  1. This Form 4 is being filed by Bank of America Corporation ("BAC"), a Delaware corporation and bank holding company registered under the Bank Holding Company Act of 1956, on behalf of its subsidiaries. BAC is an indirect beneficial owner of the shares of common stock of HCA Holdings, Inc. (the "Issuer"), held indirectly through its affiliates as described in footnotes 3-5, below.
  2. Transaction executed by the error correction section of Merrill Lynch, Pierce, Fenner & Smith Incorporated ("MLPFS"), a broker-dealer and subsidiary of BAC, to correct errors made in connection with agency brokerage trades made on behalf of clients of MLPFS.
  3. ML Global Private Equity Fund, L.P., now BAML Capital Partners, ("MLGPELP Fund") may be deemed to indirectly own a portion of these shares of the Issuer's common stock by virtue of the membership interests it holds in Hercules Holding II, LLC ("Hercules"). MLGPE Ltd. is the general partner of MLGPELP Fund and is a wholly owned subsidiary of ML Global Private Equity Partners, L.P. ("MLGPEP"), the general partner of which is Merrill Lynch GP, Inc. ("ML GP"), which is a wholly owned subsidiary of Merrill Lynch Group, Inc. ("ML Group"), which is a wholly owned subsidiary of Merrill Lynch & Co., Inc. ("ML&Co."), which is a wholly owned subsidiary of BAC. The investment committee of ML Global PE LP has decision-making power over the voting and disposition of shares of portfolio investments of MLGPELP Fund, including MLGPELP Fund's investment in the Issuer. However, the consent of ML GP is expressly required in connection with any such vote or disposition.
  4. ML HCA Co-Invest, L.P. ("ML Co-Invest LP") may be deemed to indirectly own a portion of these shares of the Issuer's common stock by virtue of the membership interests it holds in Hercules. Investment decisions for ML Co-Invest LP are made by the board of directors of ML HCA Co-Invest, Ltd., a wholly owned subsidiary of MLGPELP Fund.
  5. Merrill Lynch Ventures L.P. 2001 ("ML Ventures LP") may be deemed to indirectly own a portion of these shares of the Issuer's common stock by virtue of the membership interests it holds in Hercules. Merrill Lynch Ventures, LLC ("ML Ventures LLC"), is a wholly owned subsidiary of ML Group and the sole general partner of ML Ventures LP.
  6. Hercules directly holds all the shares of the Issuer's common stock reported herein. The membership interests of Hercules are held by a private investor group, including affiliates of Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co. L.P. and MLGPELP Fund, and affiliates of the Issuer's founder Dr. Thomas F. Frist, Jr. BAC, through its affiliates, may be deemed to be a member of a group exercising voting and investment control over the shares of the Issuer's common stock held by Hercules. However, each of BAC and its affiliates disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, BAC is the beneficial owner of the securities covered by this statement except to the extent of its pecuniary interest therein.
  7. MLGPELP Fund, ML Ventures LP and certain of their permitted transferees collectively have the right under Hercules's limited liability company agreement to nominate up to three directors of the Issuer. Three employees of MLGPE Ltd. are on the board of the Issuer. Each of BAC and its other affiliates hereby disclaims its possible status as a director of the Issuer.
  8. In connection with this transaction, BAC has agreed to voluntarily remit appropriate profits, if any, to the Issuer. BAC disclaims that such transaction is subject to reporting under Section 16(a) or disgorgement under Section 16(b), and this report shall not be deemed an admission that those sections apply to such transaction.